NARI Inari Medical Inc

Price (delayed)

$80.38

Market cap

$4.01B

P/E Ratio

151.66

Dividend/share

N/A

EPS

$0.53

Enterprise value

$3.92B

Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari has developed two minimally-invasive, ...

Highlights
NARI's gross profit has soared by 150% YoY and by 24% QoQ
The revenue has surged by 141% year-on-year and by 22% since the previous quarter
The EPS has surged by 83% since the previous quarter but it has declined by 13% year-on-year
The quick ratio has plunged by 66% YoY and by 34% from the previous quarter

Key stats

What are the main financial stats of NARI
Market
Shares outstanding
49.93M
Market cap
$4.01B
Enterprise value
$3.92B
Valuations
Price to earnings (P/E)
151.66
Price to book (P/B)
18
Price to sales (P/S)
19.18
EV/EBIT
152.64
EV/EBITDA
139.32
EV/Sales
18.84
Earnings
Revenue
$208.18M
EBIT
$25.7M
EBITDA
$28.16M
Free cash flow
$9.56M
Per share
EPS
$0.53
Free cash flow per share
$0.19
Book value per share
$4.47
Revenue per share
$4.19
TBVPS
$5.1
Balance sheet
Total assets
$253.56M
Total liabilities
$31.74M
Debt
$949,000
Equity
$221.82M
Working capital
$196.59M
Liquidity
Debt to equity
0
Current ratio
7.22
Quick ratio
6.57
Net debt/EBITDA
-3.21
Margins
EBITDA margin
13.5%
Gross margin
92.1%
Net margin
12%
Operating margin
12.5%
Efficiency
Return on assets
11%
Return on equity
12.1%
Return on invested capital
29.2%
Return on capital employed
11.6%
Return on sales
12.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NARI stock price

How has the Inari Medical stock price performed over time
Intraday
-0.77%
1 week
1.06%
1 month
10.7%
1 year
14.89%
YTD
-7.92%
QTD
-13.83%

Financial performance

How have Inari Medical's revenue and profit performed over time
Revenue
$208.18M
Gross profit
$191.83M
Operating income
$26.01M
Net income
$25.02M
Gross margin
92.1%
Net margin
12%
NARI's gross profit has soared by 150% YoY and by 24% QoQ
The revenue has surged by 141% year-on-year and by 22% since the previous quarter
The company's operating margin has surged by 71% YoY
NARI's net income is up by 46% since the previous quarter

Growth

What is Inari Medical's growth rate over time

Valuation

What is Inari Medical stock price valuation
P/E
151.66
P/B
18
P/S
19.18
EV/EBIT
152.64
EV/EBITDA
139.32
EV/Sales
18.84
The EPS has surged by 83% since the previous quarter but it has declined by 13% year-on-year
The stock's price to earnings (P/E) is 28% less than its last 4 quarters average of 212.4
The equity is up by 21% year-on-year and by 3.8% since the previous quarter
The price to book (P/B) is 14% lower than the last 4 quarters average of 21.1
The revenue has surged by 141% year-on-year and by 22% since the previous quarter
The P/S is 25% below the last 4 quarters average of 25.8

Efficiency

How efficient is Inari Medical business performance
The company's return on assets rose by 41% QoQ
The return on equity has increased by 39% since the previous quarter
The return on sales has increased by 15% since the previous quarter
NARI's return on invested capital is up by 8% since the previous quarter

Dividends

What is NARI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NARI.

Financial health

How did Inari Medical financials performed over time
The quick ratio has plunged by 66% YoY and by 34% from the previous quarter
The current ratio has dropped by 64% year-on-year and by 33% since the previous quarter
Inari Medical's debt is 100% less than its equity
NARI's debt to equity has plunged by 100% from the previous quarter and by 100% YoY
Inari Medical's debt has plunged by 97% YoY and by 17% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.